SCHEMBL4923931

SCHEMBL4923931

Cc1cccc(NC(=O)c2ccccc2-c2ccccc2C(=O)NO)c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.54
LMNA P02545 3/20 0.54
HTT P42858 3/20 0.54
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 2/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 1/20 0.54
NPC1 O15118 2/20 0.54
TP53 P04637 2/20 0.54
TSHR P16473 1/20 0.54
RAB9A P51151 1/20 0.54
KMT2A Q03164 2/20 0.50
KDR P35968 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GAA P10253 2/20 0.48
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925909 0.93 HSD17B10 (0.58) HSD17B10LMNAHTTALDH1A1KDM4E
SCHEMBL4923911 0.84 KDR (0.54) HSD17B10LMNAHTTALDH1A1KDM4E
SCHEMBL4927648 0.80 GAA (0.69) HSD17B10LMNAHTTALDH1A1KDM4E
SCHEMBL10057829 0.79 LMNA (0.64) HSD17B10LMNAHTTALDH1A1KDM4E
SCHEMBL9493594 0.78 ALDH1A1 (0.62) HSD17B10HTTALDH1A1KDM4EHPGD
SCHEMBL4916420 0.76 GAA (0.80) HSD17B10LMNAALDH1A1KDM4ENPC1
SCHEMBL4923542 0.76 TP53 (0.56) LMNAHTTALDH1A1KDM4EHPGD
SCHEMBL4925144 0.76 HDAC1 (0.56) HSD17B10HTTALDH1A1KDM4EMAPK1
SCHEMBL3026631 0.76 GAA (0.64) HSD17B10LMNAHTTALDH1A1KDM4E
SCHEMBL2700502 0.74 HTT (0.60) HSD17B10LMNAHTTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HSD17B10 2205/4885LMNA 4560/4885HTT 2317/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HSD17B10 2336/4885LMNA 4579/4885HTT 2202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.